t42 IoT Tracking Solutions reports improved EBITDA in H1 2025

t42 IoT Tracking Solutions (AIM:TRAC) reported significantly improved financial performance for H1 2025, with revenues increasing to $2.3 million from $2.0 million and adjusted EBITDA turning positive at $239,000, compared to a $25,000 loss in H1 2024. Gross margin improved to 48% due to cost reductions, while Lokies device sales nearly tripled to 5,000 units. The company also enhanced its financial flexibility by extending convertible loan maturities to 2027 and secured a post-period contract valued over $2.5 million, reinforcing expectations for strong full-year Lokies revenue growth.

Analysis

t42 IoT Tracking Solutions (AIM:TRAC) reported a significant operational and financial turnaround in its first-half 2025 results, signaling a potential growth inflection point. The company achieved a pivotal shift to profitability, posting a positive adjusted EBITDA of $239,000 compared to a $25,000 loss in the prior-year period. This was driven by a 15% year-over-year revenue increase to $2.3 million and an improved gross margin of 48%, up from 45%, resulting from production cost efficiencies. The core driver of this performance was a nearly threefold increase in sales of its Lokies tracking devices, which reached 5,000 units. Furthermore, t42 has enhanced its financial stability by extending the maturity of two secured convertible loan notes to the end of 2027, providing greater flexibility for growth investments. The outlook is strongly supported by a post-period contract win valued at over $2.5 million and explicit company guidance for at least 200% year-over-year growth in Lokies revenues for the full year 2025.

Key Decisions for Investors

• Investors should view the positive EBITDA, accelerating unit sales, and significant new contract win as strong validation of t42's strategy, suggesting the company may be at a key inflection point for growth.
• It is crucial to monitor the execution on the recently secured $2.5 million contract and track subsequent sales momentum to verify the company's ability to meet its ambitious full-year guidance of 200% growth in Lokies revenues.
• While the loan note extension alleviates immediate balance sheet pressure, investors should continue to scrutinize cash flow and capital management as the company scales to fund its expansion.